Jøran H.
- Country
- Norway
- Department
- Hormon, overvekt og ernæringsavdelingen
Research Overview
- Evaluation of Semaglutide and Low Energy Diet in Adolescents with Obesity: A Randomized Controlled Trial
- A Phase 3, randomised, double-blind, parallel-group, event-driven, cardiovascular safety study with BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity with established cardiovascular disease (CVD) or chronic kidney disease, and/or at least two weight-related complications or risk factors for CVD
Data & Insights
Has run more than one trial at 1 of 173 partner sites.
Specializations
Obesity Management
The investigator specializes in obesity treatment approaches, with particular emphasis on innovative therapeutic interventions for different age groups.
- Adolescent obesity management
- Behavioral therapy integration
- Electronic health interventions
Their research encompasses both traditional and technology-enhanced treatment modalities for weight management.
Cardiovascular Health
The investigator focuses on the intersection of obesity and cardiovascular health, exploring therapeutic approaches that address both conditions.
- Cardiovascular safety assessment
- Coronary health monitoring
- Heart failure prevention
Their work evaluates cardiovascular outcomes in patients with obesity undergoing various therapeutic interventions.
Therapeutic Innovation
The investigator's work involves evaluation of novel therapeutic agents and treatment approaches in obesity management.
- Digital therapeutic platforms
- Combined treatment modalities
- Long-term intervention studies
Their research integrates pharmaceutical interventions with behavioral and technological approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.